Business Wire

Thermo Fisher Scientific Updates Chromosomal Microarray Analysis Solutions to Comply with IVDR Regulation

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ ...
Hosted on MSN

Metropolis Healthcare acquires Core Diagnostics to expand cancer testing services

Metropolis Healthcare Limited on Monday announced the acquisition of Delhi NCR-based Core Diagnostics for Rs 246.8 crore. The acquisition aims to enhance Metropolis’ cancer testing capabilities and ...
Business Wire

Variantyx Expands Its Reproductive Health Offerings with Launch of a Direct Replacement for Chromosomal Microarray Analysis

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx, a leader in genomic precision medicine, today announced the launch of its IriSight™ CNV Analysis - a whole genome-based test for the detection of ...
Hosted on MSN

Dr Lal PathLabs, Metropolis, other diagnostic stocks fall up to 3% after Amazon launches home testing service

Shares of diagnostics companies declined on Monday after Amazon India announced the launch of home diagnostics services across six major cities. Dr Lal PathLabs and Metropolis fell up to 3% in early ...